VIR
Vir Biotechnology Inc
NASDAQ: VIR · HEALTHCARE · BIOTECHNOLOGY
$10.22
+1.34% today
Updated 2026-04-30
Market cap
$1.72B
P/E ratio
—
P/S ratio
25.02x
EPS (TTM)
$-3.16
Dividend yield
—
52W range
$4 – $12
Volume
4.0M
Vir Biotechnology Inc (VIR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-66.38M | $-94.10M | $-129.63M | $-190.94M | $-47.59M | $1.66B | $-778.78M | $-446.35M | $-391.78M |
| Capital expenditures | $2.74M | $8.19M | $8.94M | $6.55M | $21.82M | $68.01M | $21.57M | $7.30M | $4.83M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $4.78M | $5.05M | $8.72M | $27.60M | $83.78M | $102.08M | $111.32M | $78.46M | $49.07M |
| Free cash flow | $-69.12M | $-102.29M | $-138.57M | $-197.49M | $-69.41M | $1.60B | $-800.36M | $-453.65M | $-396.61M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | $0.00 | $0.00 | — | $328.67M | $-88.07M | — | — | — | — |